Abstract:MicroRNAs (miRNAs or miRs) play an important role in the tumorigenesis and progression of breast cancer. However, the function of miR-28-5p in breast cancer migration has yet to be determined. In the present study, Human MicroRNA Expression Database (HMED) analysis revealed that the expression level of miR-28-5p was significantly lower in breast cancer tissue than in normal breast tissue. Kaplan -Meier plotter (KMPLOT) analysis revealed that the low expression level of miR-28-5p was associated with a poor survival in breast cancer. In addition, reverse transcription-quantitative PCR (RT-qPCR) revealed that the expression of miR-28-5p was significantly lower in breast cancer cell lines compared with that in human mammary epithelial cells (HMECs). Moreover, transfection with miR-28-5p mimics suppressed the migration of MCF-7 cells, whereas an miR-28-5p inhibitor exerted the opposite effect. Gene chip assay identified 648 differentially expressed genes (DEGs) in cells overexpressing miR-28-5p. The DEGs are enriched in the 'focal adhesion' and 'pathway in cancer' pathways. The expression levels of Ras-related protein Rap-1b (RAP1B), WD repeat and SOCS box containing 2 (WSB2) and vascular endothelial growth factor A (VEGFA) were confirmed by RT-qPCR. Furthermore, transfection with miR-28-5p mimics decreased WSB2 expression, whereas the miR-28-5p inhibitor increased the expression of WSB2, at both the transcriptional and translational levels. miR-28-5p targets the 3 ' UTR of WSB2, and the binding site is conserved in multiple species, with a consensus motif of 5 '-AGCUCCUU-3 '. Moreover, WSB2 overexpression promoted the migration of MCF-7 cells which had been inhibited by miR-28-5p. UALCAN analysis revealed that WSB2 was significantly upregulated in primary breast tumor tissue, and a high expression level of WSB2 was associated with a poor survival in breast cancer. Furthermore, immunohistochemistry revealed that the expression of WSB2 was markedly higher in breast cancer tissue compared with that in adjacent normal breast tissue. Taken together, the findings of the present study demonstrate that miR-28-5p inhibits the migration of breast cancer cells by regulating WSB2 expression, and the miR-28-5p/WSB2 axis may be a novel therapeutic target in breast cancer.

MiR-219a-5p Inhibits Michigan Cancer Foundation-7 (MCF-7) Cell Migration by Regulating Zinc Finger E-Box Binding Homeobox 1 (ZEB1) Expression

Mir-145 Suppresses Breast Cancer Cell Migration by Targeting FSCN-1 and Inhibiting Epithelial-Mesenchymal Transition.

Mir-219A-5p Inhibits Breast Cancer Cell Migration and Epithelial-Mesenchymal Transition by Targeting Myocardin-Related Transcription Factor A.

Mir-433 Inhibits Breast Cancer Cell Growth Via the MAPK Signaling Pathway by Targeting Rap1a

MiR-526b Suppresses Cell Proliferation, Cell Invasion and Epithelial-Mesenchymal Transition in Breast Cancer by Targeting Twist1

MicroRNA-495 Induces Breast Cancer Cell Migration by Targeting JAM-A

miR ‐223‐3p targets FBXW7 to promote epithelial‐mesenchymal transition and metastasis in breast cancer

Microrna-154 Inhibits Growth and Invasion of Breast Cancer Cells Through Targeting E2f5

miR-144 functions as a tumor suppressor in breast cancer through inhibiting ZEB1/2-mediated epithelial mesenchymal transition process.

MiR-886-5p inhibition inhibits growth and induces apoptosis of MCF7 cells.

miR-28-5p inhibits the migration of breast cancer by regulating <i>WSB2</i>

MicroRNA-34a Suppresses Breast Cancer Cell Proliferation and Invasion by Targeting Notch1

Mir‑139‑3p Suppresses the Invasion and Migration Properties of Breast Cancer Cells by Targeting RAB1A

MicroRNA-1236-3p Inhibits Proliferation and Invasion of Breast Cancer Cells by Targeting ZEB1

Mir-204 Regulates the Biological Behavior of Breast Cancer MCF-7 Cells by Directly Targeting FOXA1

MicroRNA-34a targets epithelial to mesenchymal transition-inducing transcription factors (EMT-TFs) and inhibits breast cancer cell migration and invasion

MicroRNA-7 Inhibits Epithelial-to-mesenchymal Transition and Metastasis of Breast Cancer Cells Via Targeting FAK Expression.

miR-623 suppresses cell proliferation, migration and invasion through direct inhibition of XRCC5 in breast cancer

miR-181a-5p Inhibits Cancer Cell Migration and Angiogenesis via Downregulation of Matrix Metalloproteinase-14.

Downregulation of hsa_circ_0011946 suppresses the migration and invasion of the breast cancer cell line MCF-7 by targeting RFC3.

Tumor Suppressive Microrna-193B Promotes Breast Cancer Progression Via Targeting DNAJC13 and RAB22A.